Company: PTPI
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001104659-25-111338
Chunk: 3

Company: Petros Pharmaceuticals, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1F
Chunk 3
---
1,000,000 and 0 shares authorized at September 30, 2025, and December 31, 2024, respectively, 0 and 0 shares issued and outstanding as of September 30, 2025, and December 31, 2024, respectively​​ —​​ —Common stock (par value $0.0001 per share, 7,000,000,000 and 250,000,000 shares authorized at September 30, 2025, and December 31, 2024, respectively; 42,284,502 and 421,124 shares issued and outstanding as of September 30, 2025, and December 31, 2024, respectively)​  4,228​ ​ 42​​​​​​​Additional paid-in capital​  114,322,129​ ​ 105,740,751Accumulated deficit​  (110,958,270)​ ​ (113,208,371)Total Stockholders’ Equity (Deficit)​  3,368,087​ ​ (7,467,578)​​​​​​​Total Liabilities and Stockholders’ Equity (Deficit)​$ 6,133,468​$ 10,635,310

​

The accompanying Notes are an integral part of the Unaudited Condensed Consolidated Financial Statements.

​